Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review.
about
The potential role of iodine-123 metaiodobenzylguanidine imaging for identifying sustained ventricular tachycardia in patients with cardiomyopathyNew SPECT and PET radiopharmaceuticals for imaging cardiovascular diseaseCardiovascular molecular imaging: focus on clinical translationFor what endpoint does myocardial 123I-MIBG scintigraphy have the greatest prognostic value in patients with chronic heart failure? Results of a pooled individual patient data meta-analysis.Cardiac Iodine-123-Meta-Iodo-Benzylguanidine Uptake in Carotid Sinus Hypersensitivity123I-ioflupane brain SPECT and 123I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders.Nuclear medicine in the management of patients with heart failure: guidance from an expert panel of the International Atomic Energy Agency (IAEA)A prediction model for 5-year cardiac mortality in patients with chronic heart failure using ¹²³I-metaiodobenzylguanidine imaging.Multicenter cross-calibration of I-123 metaiodobenzylguanidine heart-to-mediastinum ratios to overcome camera-collimator variations.Dysinnervated but viable myocardium in ischemic heart disease.Novel iodinated tracers, MIBG and BMIPP, for nuclear cardiology.Vascular time-activity variation in patients undergoing ¹²³I-MIBG myocardial scintigraphy: implications for quantification of cardiac and mediastinal uptakeThe role of nuclear imaging in the failing heart: myocardial blood flow, sympathetic innervation, and future applications.Renal Function in Relation to Cardiac (123)I-MIBG Scintigraphy in Patients with Chronic Heart Failure.Reproducibility of planar (123)I-meta-iodobenzylguanidine (MIBG) myocardial scintigraphy in patients with heart failure.The prognostic value of estimated glomerular filtration rate, amino-terminal portion of the pro-hormone B-type natriuretic peptide and parameters of cardiopulmonary exercise testing in patients with chronic heart failureThe impact of acquisition time of planar cardiac (123)I-MIBG imaging on the late heart to mediastinum ratioPrediction of all-cause death using (11)C-hydroxyephedrine positron emission tomography in Japanese patients with left ventricular dysfunction.Impact of mediastinal, liver and lung (123)I-metaiodobenzylguanidine ( (123)I-MIBG) washout on calculated (123)I-MIBG myocardial washout.Cardiac I123-MIBG correlates better than ejection fraction with symptoms severity in systolic heart failure.Diagnostic performance of myocardial innervation imaging using MIBG scintigraphy in differential diagnosis between dementia with lewy bodies and other dementias: a systematic review and a meta-analysis.Variation of heart-to-mediastinal ratio in (123)I-mIBG cardiac sympathetic imaging: its affecting factors and potential corrections.MIBG scintigraphy in differential diagnosis of Parkinsonism: a meta-analysis.Use of cardiac radionuclide imaging to identify patients at risk for arrhythmic sudden cardiac death.Cardiac autonomic imaging with SPECT tracers.PET and SPECT in heart failure.Traditional and novel methods to assess and prevent chemotherapy-related cardiac dysfunction noninvasively.The sympathetic nervous system and heart failure.Radionuclide imaging of cardiac sympathetic innervation in heart failure: unlocking untapped potential.Radionuclide imaging of neurohormonal system of the heartLipophilic Statin Versus Rosuvastatin (Hydrophilic) Treatment for Heart Failure: a Meta-Analysis and Adjusted Indirect Comparison of Randomised Trials.SPECT and PET in ischemic heart failure.Current Clinical Applications and Next Steps for Cardiac Innervation Imaging.Iodine-123 metaiodobenzylguanidine scintigraphy for the assessment of cardiac sympathetic innervation and the relationship with cardiac autonomic function in healthy adults using standardized methods.123 I-MIBG imaging for detection of anthracycline-induced cardiomyopathy.The role of nuclear cardiac imaging in risk stratification of sudden cardiac death.Impact of aging on cardiac sympathetic innervation measured by 123I-mIBG imaging in patients with systolic heart failure.Prognostic significance of (123)I-mIBG SPECT myocardial imaging in heart failure: differences between patients with ischaemic and non-ischaemic heart failure.Cardiac autonomic nervous system in heart failure: imaging technique and clinical implications.Molecular imaging in heart failure patients.
P2860
Q27011223-6E49A655-2B74-4A9F-AAD8-D2FA11A65EACQ27011866-2EE8315E-2657-4B56-889C-C4CDEEE9DF5CQ30470859-82416B96-B014-49BA-B773-0471ECCB9C61Q30789946-D2DF854D-73E8-4EF0-890D-C209006AB143Q33165838-E664FF43-B20B-456C-9778-BE6E74816BFAQ33760571-530C644A-0BFA-478D-A350-21A66BB98E04Q33824869-137E059C-DE7C-486D-B4C1-F55080E02DA3Q34006985-35283547-6723-412E-96FF-6E55D856A41AQ34204557-C78CFFD6-9580-4E1D-82AB-0843DD60C88BQ34519327-E6AF156A-2D6A-4F65-9EEF-FEC783FB48BFQ34544890-8178D55A-E3E2-434A-9ADD-7A5DCD6CA061Q34981377-D4D4247A-A53D-4D9C-A9A2-46410166D519Q35053611-90A96FD6-6A6D-433E-9A0D-C420B71C810FQ35990837-5A435321-FD11-47EA-BF5D-691419986FBEQ36279462-083D49AF-04F7-4FB6-9446-A1DEE1384C64Q36417668-F9CE3E2B-A7BA-4AB2-BB2D-8649CCA77E8DQ36427043-62C15224-D06C-4616-A24C-70BC70202F6CQ37127700-CA9A940C-8D0D-4DAF-BED9-5C2861AA079AQ37258171-28AC4264-C2EB-44BD-8834-6D3E92ED06E7Q37720773-22F459D0-2E75-4C86-8752-F607283D7657Q37811053-27538034-4A71-4065-9526-6E380ADFFAC3Q37827405-49ED6ABC-93C0-4AB8-89EA-0AD66F7238D8Q37906394-EB96BF5B-608D-4E31-BF76-C9E25A364E88Q37963281-F5B83BA6-7E43-4558-9B31-BF37F4A1A748Q38063172-CA32F012-D6EF-4FD6-8B00-272C0E9C0709Q38075810-2C91D8EC-1545-445D-959B-8D7666E9B8E8Q38097736-0DE036FB-863B-4926-81A4-F1DF121D1BD1Q38167053-7490EC60-E661-4DDA-B9A1-FB1B0D90649DQ38241069-475A55EF-3434-451F-B056-185BDB81760DQ38397104-AA331E42-6A65-4E49-9F73-B8CEFE80B406Q38701402-AC28FE64-0611-473A-808A-EFAEB05FC907Q38985171-83FDE261-60B2-4AE2-A477-68402D9D5218Q39022541-2FB148A1-6FEA-4369-BB6E-EAE99FA227CEQ39145397-B4DA5E8B-FCE5-4915-AEE6-4ED690DF6999Q39157770-58C4AF6B-C64B-4920-BC68-5B6B13C29D65Q39548660-7EF38723-E141-41CF-B360-754E1EDEFA59Q39692006-A1B117FF-0531-4955-B9E1-D8A00E20A86EQ40296183-77430D2D-311F-4315-BF6A-8991652EA0DFQ42245038-99C37FDC-B19F-4622-AA1B-2F4D9FD8601AQ42345701-A0CB6043-490A-4B48-8B7D-1B98E78B01B2
P2860
Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prognostic value of myocardial ...... failure: a systematic review.
@en
Prognostic value of myocardial 123I-metaiodobenzylguanidine
@nl
type
label
Prognostic value of myocardial ...... failure: a systematic review.
@en
Prognostic value of myocardial 123I-metaiodobenzylguanidine
@nl
prefLabel
Prognostic value of myocardial ...... failure: a systematic review.
@en
Prognostic value of myocardial 123I-metaiodobenzylguanidine
@nl
P2093
P2860
P356
P1476
Prognostic value of myocardial ...... failure: a systematic review.
@en
P2093
Berthe L F van Eck-Smit
G Aernout Somsen
Hein J Verberne
P2860
P304
P356
10.1093/EURHEARTJ/EHN113
P577
2008-03-17T00:00:00Z